Financials

Discussions Technicals Seasonals

4117 fundamentals

Overview Statements Statistics Dividends Earnings Revenue

Key facts

—

—

—

—

—

—

—

—

About

General Biologicals Corp. engages in research, development, manufacture and trade of diagnostics and pharmaceuticals. The company provides anti-bacterial peptide in the areas of pharmaceutical, cosmetics, and oral products. Its products include COVID-19 and digital pathology solutions, in vitro diagnostic (IVD) kits & system, HIV ELISA blood screening, human plasma and antibody biomaterials. The company was founded on June 11, 1984 and is headquartered in Hsinchu, Taiwan.

Valuation

Fundamental metrics to determine fair value of the stock

Summary

No data available

There's currently no market capitalization, revenue or net income data to show.

Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends

4117 has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company